The dynamic tumor–stromal crosstalk: implications of ‘stromal-hot’ tumors in the process of epithelial–mesenchymal transition in breast cancer

[1]  Tao Zhang,et al.  Targeting the tumor stroma for cancer therapy , 2022, Molecular Cancer.

[2]  J. Costello,et al.  Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8+ T Cell Immunity , 2022, Cancers.

[3]  Ruyi Xie,et al.  microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway , 2022, European journal of histochemistry : EJH.

[4]  Yong Teng,et al.  SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3 , 2021, Journal of experimental & clinical cancer research : CR.

[5]  M. Jolly,et al.  Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity , 2021, Cancers.

[6]  E. Tagliabue,et al.  Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences , 2021, International journal of molecular sciences.

[7]  Yingchun Liang,et al.  MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect , 2020, Frontiers in Cell and Developmental Biology.

[8]  R. Hass,et al.  Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness , 2020, Cancers.

[9]  A. Bishayee,et al.  Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression , 2020, Biomolecules.

[10]  R. Piñeiro,et al.  Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs) , 2020, Cancers.

[11]  Hu Li,et al.  MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer , 2020, Technology in cancer research & treatment.

[12]  Kazuhiro Yoshida,et al.  Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation , 2020, International journal of molecular sciences.

[13]  P. Lin.  Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis , 2020, Cells.

[14]  Tamara L. Kinzer-Ursem,et al.  The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites , 2020, Cancers.

[15]  Hae-Yun Jung,et al.  Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer , 2020, Cancers.

[16]  I. Georgakopoulos-Soares,et al.  EMT Factors and Metabolic Pathways in Cancer , 2020, Frontiers in Oncology.

[17]  Zhijie Lin,et al.  The effect of overexpression of the HOXD10 gene on the malignant proliferation, invasion, and tumor formation of pancreatic cancer cell PANC-1. , 2020, Gland surgery.

[18]  M. Franchi,et al.  miR-200b restrains EMT and aggressiveness and regulates matrix composition depending on ER status and signaling in mammary cancer , 2020, Matrix biology plus.

[19]  Wei Liu,et al.  SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming , 2020, Applied Biochemistry and Biotechnology.

[20]  A. Qian,et al.  MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1 , 2020, Frontiers in Genetics.

[21]  Xu Zhang,et al.  Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer , 2019, Cell Death & Disease.

[22]  Hongbin Wang,et al.  MicroRNA-181d-5p-Containing Exosomes Derived from CAFs Promote EMT by Regulating CDX2/HOXA5 in Breast Cancer , 2019, Molecular therapy. Nucleic acids.

[23]  M. Dieci,et al.  Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives , 2019, Cancers.

[24]  Hiroshi I. Suzuki,et al.  Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1 , 2019, Molecular oncology.

[25]  C. Caserta,et al.  The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System , 2019, Cells.

[26]  J. Schneider,et al.  Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities , 2019, Cancers.

[27]  D. Finkelstein,et al.  The Laminin-α1 Chain-Derived Peptide, AG73, Binds to Syndecans on MDA-231 Breast Cancer Cells and Alters Filopodium Formation , 2019, Analytical cellular pathology.

[28]  E. Dejana,et al.  Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells , 2019, BMC Cancer.

[29]  Ting-Ting Li,et al.  Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics , 2019, BioMed research international.

[30]  J. Morales-Montor,et al.  Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology , 2019, Front. Immunol..

[31]  R. Xiang,et al.  miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer , 2018, Oncogenesis.

[32]  S. Pitson,et al.  The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity , 2018, Front. Oncol..

[33]  Hao Huang,et al.  Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances , 2018, Sensors.

[34]  He-da Zhang,et al.  MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer , 2018, Journal of oncology.

[35]  S. Tai,et al.  Snail-overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes , 2018, Neoplasia.

[36]  A. Musti,et al.  Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT , 2018, International journal of molecular sciences.

[37]  S. Sen,et al.  CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer , 2018, Scientific Reports.

[38]  D. Beebe,et al.  Mammary fibroblasts reduce apoptosis and speed estrogen-induced hyperplasia in an organotypic MCF7-derived duct model , 2018, Scientific Reports.

[39]  H. Ishinaga,et al.  Let-7c inhibits migration and epithelial–mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2 , 2018, Oncotarget.

[40]  Xuetao Cao,et al.  CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion , 2017, Oncotarget.

[41]  S. Wiemann,et al.  MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells , 2017, Cell Death & Disease.

[42]  W. Jiang,et al.  MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells , 2017, British Journal of Cancer.

[43]  S. Anant,et al.  Stromal contributions to the carcinogenic process , 2017, Molecular carcinogenesis.

[44]  M. Jackson,et al.  Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling , 2017, Oncogene.

[45]  S. Glynn,et al.  Mesenchymal stem cells: key players in cancer progression , 2017, Molecular Cancer.

[46]  Xinbing Sui,et al.  Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities , 2017, Oncotarget.

[47]  Ming Yan,et al.  Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment , 2016, Oncotarget.

[48]  M. Zhong,et al.  Multiple Roles of WNT5A in Breast Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[49]  W. Han,et al.  Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism , 2016, bioRxiv.

[50]  Kristina Stumpf,et al.  Tumor-associated stromal cells as key contributors to the tumor microenvironment , 2016, Breast Cancer Research.

[51]  A. Wells,et al.  Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells , 2016, BMC Cancer.

[52]  M. Iorio,et al.  Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts , 2016, Cell Death and Disease.

[53]  M. Laukkanen,et al.  Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression , 2015, Stem cells international.

[54]  Shukun Tang,et al.  Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling , 2015, Cell Death and Differentiation.

[55]  Juan Shi,et al.  Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer , 2015, Scientific Reports.

[56]  V. Tkachuk,et al.  miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells. , 2015, Experimental cell research.

[57]  H. Ditzel,et al.  Fyn is an important molecule in cancer pathogenesis and drug resistance. , 2015, Pharmacological research.

[58]  Jianping Chen,et al.  miR-200c inhibits breast cancer proliferation by targeting KRAS , 2015, Oncotarget.

[59]  W. Jung,et al.  Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells , 2015, Breast Cancer Research and Treatment.

[60]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[61]  Peixin Yang,et al.  Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer , 2015, Breast Cancer Research and Treatment.

[62]  N. Kosaka,et al.  Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells , 2014, Science Signaling.

[63]  K. Yanagihara,et al.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer , 2014, Cancer science.

[64]  Yu-mei Feng,et al.  Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling , 2013, British Journal of Cancer.

[65]  A. Musti,et al.  GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs). , 2014, The international journal of biochemistry & cell biology.

[66]  Y. Jeon,et al.  Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells , 2013, PloS one.

[67]  Paola Chiarugi,et al.  Microenvironment and tumor cell plasticity: an easy way out. , 2013, Cancer letters.

[68]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[69]  P. Xie,et al.  M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway , 2013, Laboratory Investigation.

[70]  R. Bjerkvig,et al.  Mesenchymal stem cell signaling in cancer progression. , 2013, Cancer treatment reviews.

[71]  Armand Keating,et al.  Mesenchymal stromal cells , 2006, Stem Cell Biology and Regenerative Medicine.

[72]  Jianhua Wang,et al.  Stromal cells in tumor microenvironment and breast cancer , 2013, Cancer and Metastasis Reviews.

[73]  Yanqiu Zhao,et al.  TISSUE-SPECIFIC STEM CELLS Inhibition of TGF-b/Smad Signaling by BAMBI Blocks Differentiation of Human Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts and Abolishes Their Protumor Effects , 2012 .

[74]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[75]  Armand Keating,et al.  Mesenchymal stromal cells: new directions. , 2012, Cell stem cell.

[76]  S. Chiou,et al.  Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. , 2012, Lung cancer.

[77]  Zainab N. Khan,et al.  Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. , 2012, Cancer cell.

[78]  A. Verma,et al.  Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition , 2012, Cancer Microenvironment.

[79]  J. Gong,et al.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer , 2012, Molecular and Cellular Biochemistry.

[80]  Markus Ringnér,et al.  Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties , 2011, PloS one.

[81]  Bo Hu,et al.  Platelet-derived growth factor signaling in human malignancies , 2011, Chinese journal of cancer.

[82]  M. Ewen,et al.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.

[83]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[84]  N. Miller,et al.  Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT) , 2010, Breast Cancer Research and Treatment.

[85]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[86]  Erik W Thompson,et al.  Epithelial to mesenchymal transition and breast cancer , 2009, Breast Cancer Research.

[87]  Yao‐Hua Song,et al.  Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. , 2009, Cancer letters.

[88]  Erik Sahai,et al.  Localised and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility , 2009, Nature Cell Biology.

[89]  G. Hu,et al.  Epithelial-mesenchymal transition and cell cooperativity in metastasis. , 2009, Cancer research.

[90]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[91]  M. Stack,et al.  Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion , 2007, Nature Cell Biology.

[92]  Charles P. Lin,et al.  Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. , 2007, Blood.

[93]  Howard Y. Chang,et al.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation , 2006, Proceedings of the National Academy of Sciences.

[94]  M. O'hare,et al.  Tumour-Stromal Interactions in Breast Cancer: The Role of Stroma in Tumourigenesis , 2005, Tumor Biology.

[95]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[96]  P. Allavena,et al.  Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. , 2004, Seminars in cancer biology.

[97]  G. Prindull,et al.  Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. , 2004, Blood.

[98]  B. Hinz,et al.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. , 2001, Molecular biology of the cell.

[99]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[100]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[101]  W. Sterry,et al.  Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA. , 1996, European journal of cancer.

[102]  E. Hay,et al.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.